AN2 Therapeutics grants inducement equity awards under Rule 5635(c)(4)
AN2 Therapeutics (NASDAQ: ANTX) announced inducement equity awards to Cameron Trenor, M.D., its newly-appointed Chief Medical Officer, under Listing Rule 5635(c)(4).
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.